Evidence map›Paper›PMID 32398875›Full record

ArticleNature medicine2020

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.

Mingfeng Liao, Yang Liu, Jing Yuan, Yanling Wen, Gang Xu, Juanjuan Zhao, Lin Cheng, Jinxiu Li, Xin Wang, Fuxiang Wang and 4 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Nature medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05455034 (Single-cell Sequencing of Bronchoalveolar Lavage Fluid to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis), which is not on this map. Cited by 1,754 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,754citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05455034 phase1 / phase2recruitingnot on this mapstarted 2023, after this paper: background citation

Single-cell Sequencing of Bronchoalveolar Lavage Fluid to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis

TypeinterventionalSponsorXinqiao Hospital of ChongqingRan2023 to 2025Enrolled40ConditionsPneumonitisArmssingle-cell sequencing
3 · Its place in the literature

Who cites it

1,754 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Mucosal immunity and vaccine development.Signal transduction and targeted therapy · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Monocytes in pneumonia: Functional plasticity and innate memory (Review).International journal of molecular medicine · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

1,694 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Mingfeng Liao *Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
Yang Liu *Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
Jing Yuan *Department for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
Yanling WenInstitute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
Gang XuInstitute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
Juanjuan ZhaoInstitute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
Lin ChengInstitute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
Jinxiu LiDepartment for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
Xin WangInstitute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
Fuxiang WangDepartment for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
Lei LiuInstitute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China. liulei3322@aliyun.com.
Ido AmitDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel. ido.amit@weizmann.ac.il.ORCID http://orcid.org/0000-0003-2968-877X
Shuye ZhangShanghai Public Health Clinical Center, Fudan University, Shanghai, China. zhangshuye@shphc.org.cn.ORCID http://orcid.org/0000-0002-4749-6790
Zheng ZhangInstitute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China. zhangzheng1975@aliyun.com.ORCID http://orcid.org/0000-0002-3544-1389

Funding

Shenzhen Science and Technology Innovation Commission 202002073000002
6 · The paper itself

Abstract

Respiratory immune characteristics associated with Coronavirus Disease 2019 (COVID-19) severity are currently unclear. We characterized bronchoalveolar lavage fluid immune cells from patients with varying severity of COVID-19 and from healthy people by using single-cell RNA sequencing. Proinflammatory monocyte-derived macrophages were abundant in the bronchoalveolar lavage fluid from patients with severe COVID-9. Moderate cases were characterized by the presence of highly clonally expanded CD8

Indexed as

Single-Cell AnalysisBetacoronavirusBronchoalveolar Lavage FluidCD8-Positive T-LymphocytesCoronavirus InfectionsCOVID-19HumansPandemicsPneumonia, ViralSARS-CoV-2

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.